Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific Neutralization.

Mack, Philip C; Hirsch, Fred R; Bunn, Paul A; Minna, John D

Mack, Philip C; Hirsch, Fred R; Bunn, Paul A; Minna, John D.

Mack PC; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY.
Hirsch FR; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY.
Bunn PA; Department of Internal Medicine, University of Colorado Cancer Center, Denver, CO.
Minna JD; Departments of Internal Medicine and Pharmacology, Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX.

J Clin Oncol ; 40(33): 3787-3789, 2022 Nov 20.

Article in English | MEDLINE | ID: covidwho-2002257

Subject(s)

COVID-19 Vaccines; COVID-19; Lung Neoplasms; Humans; Antibodies, Viral; Antibody Formation; COVID-19/epidemiology; COVID-19/prevention & control; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Lung Neoplasms Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: J Clin Oncol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google